Advertisement

Case Studies of Patients with Glioblastoma Multiforme Treated with Boron Neutron Capture Therapy at the Brookhaven Medical Research Reactor

  • E. H. Elowitz
  • J. Capala
  • J. A. Coderre
  • D. S. Cohen
  • A. Z. Diaz
  • D. D. Joel
  • A. D. Chanana

Abstract

Over the past decade, research at Brookhaven National Laboratory (BNL) and other places in the world has led to several significant advances in boron neutron capture therapy (BNCT) technology. These include the development of epithermal neutron beams1 as well as more tumor-specific boron compounds.2 In 1994, a Phase I/II clinical trial of BNCT using intravenous p-boronophenylalanine-fructose (BPA-F) and epithermal neutrons was initiated to determine both the safety and possible efficacy of BNCT for glioblastoma multiforme.3 As with any new therapy, a practical clinical experience with BNCT has been gained over time. Specific management issues seen in this trial have involved the use of steroid medication, early neurological deficits, seizure management, and BNCT-related necrosis.

Keywords

Glioblastoma Multiforme Epithermal Neutron Brookhaven National Laboratory Peritumoral Edema Expressive Aphasia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    H.B. Liu, R.M. Brugger, D.D. Greenberg, D.C. Rorer, J.P. Hu, and H.M. Hauptman, Enhancement of the epithermal neutron bean used for boron neutron capture therapy, Int J Radiat Oncol Biol Phys, 28:1149–1156, 1994.PubMedCrossRefGoogle Scholar
  2. 2.
    E.H. Elowitz, R.M. Bergland, J.A. Coderre, D.D. Joel, M. Chadha, and A.D. Chanana, Biodistribution of p-boronophenylalanine in patients with glioblastoma multiforme for use in boron neutron capture therapy, Neurosurgery, 42:463–469, 1998.PubMedCrossRefGoogle Scholar
  3. 3.
    J.A. Coderre, E.H. Elowitz, M. Chadha, R.M. Bergland, J. Capala, D.D. Joel, H.B. Liu, D.N. Slatkin, and A.D. Chanana, Boron neutron capture therapy for glioblastoma multiforme using p-boronophenylalanine and epithermal neutrons: Trial design and early clinical results, J Neurooncol, 33:141–152, 1997.PubMedCrossRefGoogle Scholar
  4. 4.
    M.S. Berger, and E. Keles, Epilepsy associated with brain tumors, in: “Brain Tumors,” A.H. Kaye and E.R. Laws, Jr., ed., Churchill Livingstone, Edinburgh, pp. 239–246, 1995.Google Scholar
  5. 5.
    M. Bilsky, and J.B. Posner, Intensive and postoperative care of intracranial tumors, in: “Neurological and Neurosurgical Intensive Care,” Raven Press, New York, pp. 309–329, 1993.Google Scholar
  6. 6.
    J.E. Marks, R.J. Baglan, S.C. Prassad, and W.F. Blank, Cerebral radio necrosis: incidence and risk in relation to dose, time, fractionation and volume, Int J Radiat Oncol Biol Phys, 7:240–252, 1981.Google Scholar
  7. 7.
    P.E. Valk, and W.P. Dillon, Radiation injury to the brain, Am J Neuroradiol, 12:45–62, 1991.PubMedGoogle Scholar
  8. 8.
    Y. Nakagawa, and H. Hatanaka, Boron neutron capture therapy: clinical brain tumor studies, J Neurooncol 33:105–115, 1997.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2001

Authors and Affiliations

  • E. H. Elowitz
    • 1
  • J. Capala
    • 2
  • J. A. Coderre
    • 2
  • D. S. Cohen
    • 1
  • A. Z. Diaz
    • 2
  • D. D. Joel
    • 2
  • A. D. Chanana
    • 2
  1. 1.Department of NeurosurgeryBeth Israel Medical CenterNew YorkUSA
  2. 2.Medical DepartmentBrookhaven National LaboratoryUptonUSA

Personalised recommendations